These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20921301)

  • 1. Elevated salivary potassium in paediatric CKD patients, a novel excretion pathway.
    Davidovich E; Davidovits M; Peretz B; Shapira J; Aframian DJ
    Nephrol Dial Transplant; 2011 May; 26(5):1541-6. PubMed ID: 20921301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation between dental calculus and disturbed mineral metabolism in paediatric patients with chronic kidney disease.
    Davidovich E; Davidovits M; Peretz B; Shapira J; Aframian DJ
    Nephrol Dial Transplant; 2009 Aug; 24(8):2439-45. PubMed ID: 19297359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary beta2-microglobulin analysis in chronic kidney disease and hemodialyzed patients.
    Michelis R; Sela S; Ben-Zvi I; Nagler RM
    Blood Purif; 2007; 25(5-6):505-9. PubMed ID: 18187941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potassium and renal failure.
    Kunis CL; Charney AN
    Compr Ther; 1981 Mar; 7(3):29-33. PubMed ID: 7237977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary glands: a new player in phosphorus metabolism.
    Savica V; Calò LA; Santoro D; Monardo P; Santoro G; Muraca U; Davis PA; Bellinghieri G
    J Ren Nutr; 2011 Jan; 21(1):39-42. PubMed ID: 21195917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach to the evaluation of hyperphosphatemia in chronic kidney disease.
    Savica V; Calò LA; Granata A; Caldarera R; Cavaleri A; Santoro D; Monardo P; Savica R; Muraca U; Bellinghieri G
    Clin Nephrol; 2007 Oct; 68(4):216-21. PubMed ID: 17969488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW; Won YW; Yi JH; Kim HJ
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of angiotensin converting enzyme inhibitors on potassium homeostasis in dialysis patients with and without residual renal function.
    Garthwaite E; Bhandari S
    Artif Organs; 2009 Aug; 33(8):641-7. PubMed ID: 19624582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating resistin concentrations in children depend on renal function.
    Nüsken KD; Kratzsch J; Wienholz V; Stöhr W; Rascher W; Dötsch J
    Nephrol Dial Transplant; 2006 Jan; 21(1):107-12. PubMed ID: 16144855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal excretion of potassium in individuals with stabilized function of a transplanted kidney].
    Schück O; Stríbrná J; Teplan V; Vítko S; Matl I; Skibová J; Stollová M
    Vnitr Lek; 1998 Jun; 44(6):315-9. PubMed ID: 9820052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary phosphate secretion in chronic kidney disease.
    Savica V; Calò L; Santoro D; Monardo P; Granata A; Bellinghieri G
    J Ren Nutr; 2008 Jan; 18(1):87-90. PubMed ID: 18089451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Potassium in renal disease].
    Lenz T; Becker B; Bergner R
    Med Klin (Munich); 2004 Jul; 99(7):355-61. PubMed ID: 15322714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta adrenergic modulation of extrarenal potassium disposal in terminal uraemia.
    Martinez Vea A; Montoliu J; Andreu L; Torras A; Gaya J; López-Pedret J; Revert L
    Proc Eur Dial Transplant Assoc; 1983; 19():756-60. PubMed ID: 6136035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hyperkalemia among hemodialysis patients in Egypt.
    Khedr E; Abdelwhab S; El-Sharkawy M; Ali M; El Said K
    Ren Fail; 2009; 31(10):891-8. PubMed ID: 20030523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.
    Guebre-Egziabher F; Bernhard J; Funahashi T; Hadj-Aissa A; Fouque D
    Nephrol Dial Transplant; 2005 Jan; 20(1):129-34. PubMed ID: 15585515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-dietary causes of hyperkalemia.
    Stover J
    Nephrol Nurs J; 2006; 33(2):221-2. PubMed ID: 16613419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compositional and oxidative analysis in the saliva and serum of predialysis chronic kidney disease patients and end-stage renal failure patients on peritoneal dialysis.
    Bibi G; Green Y; Nagler RM
    Ther Apher Dial; 2008 Apr; 12(2):164-70. PubMed ID: 18387167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches.
    Ngugi NN; McLigeyo SO; Kayima JK
    East Afr Med J; 1997 Aug; 74(8):503-9. PubMed ID: 9487416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.